Cargando…
Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing
Cell and gene therapies are finally becoming viable patient treatment options, with both T cell- and hematopoietic stem cell (HSC)-based therapies being approved to market in Europe. However, these therapies, which involve the use of viral vector to modify the target cells, are expensive and there i...
Autores principales: | Radek, Constanze, Bernadin, Ornellie, Drechsel, Katharina, Cordes, Nicole, Pfeifer, Rita, Sträßer, Pia, Mormin, Mirella, Gutierrez-Guerrero, Alejandra, Cosset, François-loïc, Kaiser, Andrew D., Schaser, Thomas, Galy, Anne, Verhoeyen, Els, Johnston, Ian C.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919281/ https://www.ncbi.nlm.nih.gov/pubmed/31578886 http://dx.doi.org/10.1089/hum.2019.157 |
Ejemplares similares
-
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
por: Piovan, Claudia, et al.
Publicado: (2017) -
Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells
por: Fenard, David, et al.
Publicado: (2013) -
Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy
por: Gutierrez-Guerrero, Alejandra, et al.
Publicado: (2020) -
An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells
por: Vamva, Eirini, et al.
Publicado: (2022) -
The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020)